This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Helmholtz-Zentrum Fur Infektionsforschung Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Anna K Hirsch: Innovator in Pharmaceutical Research
Introduction
Anna K Hirsch is a prominent inventor based in Braunschweig, Germany. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target bacterial infections. Her work is characterized by a commitment to innovation and a focus on improving medical treatments.
Latest Patents
Anna K Hirsch holds a patent for "PqsR inverse agonists." This invention relates to compounds that act as inverse agonists of PqsR, the only known receptor for the Quinolone Signal (PQS). The patent includes a pharmaceutical composition containing these compounds, as well as a combination preparation that includes at least one active pharmaceutical ingredient. The uses of these compounds extend to their application as medicaments, particularly in the treatment or prophylaxis of bacterial infections.
Career Highlights
Anna K Hirsch is affiliated with Helmholtz-Zentrum für Infektionsforschung GmbH, where she conducts her research. Her work has been instrumental in advancing the understanding of bacterial infections and developing new therapeutic strategies.
Collaborations
Some of her notable coworkers include Martin Empting and Rolf Wolfgang Hartmann. Their collaborative efforts contribute to the innovative research environment at Helmholtz-Zentrum für Infektionsforschung GmbH.
Conclusion
Anna K Hirsch is a key figure in pharmaceutical innovation, with her patent on PqsR inverse agonists showcasing her dedication to improving healthcare solutions. Her contributions continue to impact the field of medical research significantly.